Testable CYP First Exam Flashcards
Fluoxetine
Substrate of 2D6 --> norfluoxetine Inhibits 2D6 (strong) and 2C19 (moderate)
Paroxetine
Substrate 2D6
Sertraline
Inhibits 2D6 (moderate)
Citalopram/Escitalopram
Substrate of 2C19 and 3A4
Venlafaxine
Substrate of 2D6 and 3A4
Desvenlafaxine
None
Duloxetine
Substrate of 1A2 and 2D6
Inhibitor of 2D6 (moderate)
Bupropion
Inhibitor of 2D6
Mirtazapine
Substrate of 1A2, 2D6, 3A4
Trazadone
Substrate of 3A4
Amitriptyline to nortriptyline via?
2D6
Imipramine to desipramine via?
2D6
TCAs
Substrate of 2D6 and 2C19
Buspirone
Substrate of 3A4
BZDs except Lorazepam
Substrate of 3A4 (coadmin with 3A4 inhibitors is CI)
1st gen antipsychotics
Substrate of 2D6 +/- 3A4
Mod inhibitor of 2D6
Atypicals
Above your paygrade bucko
Melatonin receptor agonists
Substrates of 1A2 and 3A4
Atomoxetine
Substrate of 2D6 (major)
Celecoxib
Substrate of 2C9
Codeine –> morphine via?
2D6
Hydrocodone –> hydromorphone via?
2D6
Oxycodone –> oxymorphone via?
2D6
Tramadol –> active metabolite via?
2D6
BBW for oxycodone about interactions with? BOLD
3A4 inhibitors
Fentanyl
3A4 major
Hydrocodone and oxycodone
3A4 (major) and 2D6 (minor)
Tramadol (prodrug)
3A4 and 2D6 (major)
Codeine (prodrug)
2D6 (major)
NO CYP metab with opioids
Morphine, Hydromorphone, Oxymorphone
Dihydroergotamine
3A4 substrate
Almotriptan & Eletriptan
3A4 substrate
Sumatriptan, Rizatriptan, Zolmitriptan
Metabolized by MOA enzymes
Gepants
3A4, PgP substrates
Dementia Meds
all “fairly clean”
no cyp concerns for us
Carbamazepine
3A4 substrate (major)
Induces (strong) 2C9 and 3A4 - autoinduction**
Phenytoin
2C9 substrate
Induces (potently) 2C9 & 3A4 - autoinduction**
Lamotrigine
Does not induce or inhibit CYP enzymes
** VPA INC [lamotrigine] > 2x **
Lacosamide
Interactions: concomitant PR-prolonging drugs (b-blockers, CCBs) **
Rufinamide
Interactions: drugs that SHORTEN QT interval **
Ezogabine
Interactions: concomitant QT prolongers **
Gabapentin
Not metabolized *
Phenobarbital
Induces 2C9, 3A4 - autoinducer **
Tiagabine
3A4 substrate
Felbamate
3A4 substrate
Brivaracetam
2C19 substrate
Levodopa
MOA inhibitors block levo metabolism